50
Social media: Opportunities for pharma JD Lasica Socialmedia.biz [email protected]

Social media: opportunities for pharma

Embed Size (px)

DESCRIPTION

A comprehensive look at how social media could benefit the pharmaceutical industry, from a leading social media agency, Socialmedia.biz. Topics in the presentation include:- Social media overview - Corporate marketplace for social media- The rise of patient-driven health care and online patient communities - 3 areas for opportunity: corporate social responsibility; identifying sector influencers; creating a corporate wiki for knowledge sharing, archiving and management.

Citation preview

Page 1: Social media: opportunities for pharma

Social media: Opportunities for pharma

JD [email protected]

Page 2: Social media: opportunities for pharma

What we’ll cover

Social media overview

Corporate marketplace

Rise of online communities

3 ideas

Page 3: Social media: opportunities for pharma

What is social media?

“Any online technology or practice that lets us share

(content, opinions, insights, experiences, media) and

have a conversation about the ideas we care about.

Page 4: Social media: opportunities for pharma

The numbers

Active blogs on the Internet: 25-40 million

Social networks: 2,900. 57% of Americans have joined a social network.

Active Facebook members: 200 million

Corporations with social media campaigns: 300+

Photos on Flickr: 3 billion

Daily Twitter messages: 6 million

YouTube = 10% of all Internet traffic

Page 5: Social media: opportunities for pharma

Reality check

World Internet users by region

Asia: 650 million

Europe: 390 million

North America: 246 million

Latin America/Caribbean: 166 million

Africa: 54 million

Middle East: 45 million

Australia/Oceana: 20 million

1.57 billion users worldwide

Source: Internet World Stats, February 2009http://internetworldstats.com/stats.htm

Page 6: Social media: opportunities for pharma

Bannerads

Searchads

Sponsorships

Radio

TV/magazine

Brandsites

Blogs

Chat/discussioncomments

Otherconsumers

0% 50% 100%

78%

63%

61%

60%

56%

54%

49%

34%

26%

Source: Nielsen, Oct. 2007

Who’s commanding trust?

Page 7: Social media: opportunities for pharma

Social media principles

Be human. Be aware. Be honest. Be respectful. Be a participant. Be open. Be courageous.

Photo illustration (c) 2008 AdWeek

“The wisdom of crowds does not resist expert opinion — only dependence on a single expert opinion.”

- The Wisdom of Patients:Health care meets online social mediaCalif. HealthCare Foundation, April 2008

Page 8: Social media: opportunities for pharma

Social sites leading the way

Top 15 brands, unique monthly audience (in thousands)

Nielsen/NetRatings NetViewTwitter growth: 1,350%

Page 9: Social media: opportunities for pharma

Conversation economy

Whenever someone opens a computer, 60% of time it’s for social reasons.

To succeed in this new world,companies must leverage social mediato have conversations with customers at scale.

Page 10: Social media: opportunities for pharma

Fortune 500 still at Web 1.0Mitsubishi Lancer Evolution’s site

Page 11: Social media: opportunities for pharma

Where the action is taking place

Wikipedia

Left Lane News

Lancershop.com

evolutionm.net

Left Lane News

Source: battellemedia.com

Page 12: Social media: opportunities for pharma

American Cancer Society

“In 2009, you canʼt build a $2 million destination site and use marketing muscle to drive traffic to it.”

- David NeffAmerican Cancer Society

Page 13: Social media: opportunities for pharma

American Cancer Society, Web 2.0

Page 14: Social media: opportunities for pharma

Create a space for ‘us’

Page 15: Social media: opportunities for pharma

morebirthdays.com

Page 16: Social media: opportunities for pharma

Leveraging sharing culture

Page 17: Social media: opportunities for pharma

Let’s turn to pharma & health care

Culture clash

Regulatory realities

Emerging communities

Ideas

Page 18: Social media: opportunities for pharma

Culture challengesPharma values

Risk averse

Heavily regulated

Closed, security-focused

Controlled access to data

Authoritative, heavily filtered

Remote voice

Long lead times

IP closely guarded

Marketing-dependent

Social media valuesRisk taking

Open to all

Transparent

Sharing culture

Wisdom of crowd

Personal voice

Rapid deployment

Open source

Marketing-suspicious

Hat tip to Len Starnes, Head of Digital Marketing, Bayer Schering Pharma

Page 19: Social media: opportunities for pharma

Regulatory challenges

In pharma, we can manage chronic pain.

We can manage once-fatal diseases.So we can manage adverse event regulations.

—JD Lasica

“Compliance and regulation should not be used as a shield against engagement and communication.”

— J&J’s top social media strategist

Page 20: Social media: opportunities for pharma

Regulation: real but manageable

Page 21: Social media: opportunities for pharma

Social media life in financial sector

She blogs like a regular blogger ...

Page 22: Social media: opportunities for pharma

Here’s howbut occasionally includes a disclaimer:

Page 23: Social media: opportunities for pharma

and clever use of url shortenersShannon’s tweets sometimes end like this:

Page 24: Social media: opportunities for pharma

Health care ecosystem

To thrive in the participatory era, pharma must engage with:

Patient communities

Physician (& pharmacist) communities

Social media influencers

Its own employees & internal champions

Page 25: Social media: opportunities for pharma

The evolution of Patient Power

1993: simple search and information gathering

mid-’90s: info sharing in forums and comments

1995-2006: Stand-alone portals, websites

2005 to now: small organized communities created by patients for patients

Page 26: Social media: opportunities for pharma

Patient-driven health care'Patient-driven' health care doesn't mean patients provide for themselves but that health care is not just marketed to them from above.

It means patients want to actively participate in the delivery and potentially the design of health care technology and treatment — if not directly then indirectly by capturing, producing, analyzing and sharing their own data, observations and experiences.

The tools bring much to the patient. There’s no reason they can’t bring as much, and more, to pharma and health care providers.

Page 27: Social media: opportunities for pharma

Patient communities

Patientslikeme.com

PatientsLikeMe is a social network of people with Lou Gehrigʼs disease (ALS), MS and other health conditions. People share very personal data on prescription drug histories, health conditions, side effects, what works and what doesnʼt work.

Page 28: Social media: opportunities for pharma

Patient communities

Founder Amy Tenderich: “The first thing I did was search on the Internet. When it came to reach out to people with diabetes there was nothing that felt real or personal. There wasn’t any place for patients.”

She adds: The users of social network health sites “are more than readers — these are community members who you interact with. People are intimate in a way they never would be on a site like WebMD, for example, which offers great information but feels impersonal.”

Diabetes Mine

Page 29: Social media: opportunities for pharma

Patient communities

Iʼm Too Young For This! Cancer Foundation is a national cancer advocacy, research and support organization working exclusively on behalf of survivors under 40. There are countless little-known sites that can be helpful to young cancer survivors, says founder Matt Zachary, and “Weʼre going to tell you about it.”

imtooyoungforthis.com

Page 30: Social media: opportunities for pharma

Patient communities

Founder John LeSieur tried to find online tools that could guide autistic children around the Web, but he couldn't find anything satisfactory. So he had one built, named it the Zac Browser For Autistic Children in honor of his grandson, and is making it available to anyone for free at zacbrowser.com.

Zone for Autistic Children

Page 31: Social media: opportunities for pharma

Patient community on Facebook

Page 32: Social media: opportunities for pharma

Facebook

1. Acne 2. ADD/ADHD 3. Ear infections 4. Eye infections 5. Migraine 6. Bipolar disorder 7. Anxiety/social phobia 8. Infertility 9. Asthma10. Allergies

Top conditions Facebook users search for

Manhattan Research ePharma Consumer,no. 11, 2008

Page 33: Social media: opportunities for pharma

Patient communities

Founder Amy Gurowitz: “The focus of this blog moves between my MS Diary

(a common venue for those of us with this chronic questionable confusing conundrum that is MS) to the website I am developing (MS SoftServe, a place for people to learn about their own

disease without scaring themselves to death) and then what my life of learning experience is.”

MS-LOL: Life Of Learning

Page 34: Social media: opportunities for pharma

Social networking --> drug sales

Launched by Bayer HealthCare, evolved into a patient community.

12,000+ members200,000+ postsLed to increased global sales of Betaferon

MS-Gateway

Page 35: Social media: opportunities for pharma

Efforts by competition

SmithGlaxoKline’s

alliConnect is the official corporate blog for alli, the only

FDA-approved OTC weight loss product.

Notice the sponsorship of a networked cause for breast

cancer.

Page 36: Social media: opportunities for pharma

J&J bloggerMarc Monseau

Efforts by competition

JNJ BTW

Hundreds of reader comments on JNJ BTW & Kilmer house blogs since 2007. # of adverse events reported: 0

Page 37: Social media: opportunities for pharma

Physician social networksUSA

Sermo (75,000)Physician Connect (50,000)Student Doctor NetworkHealthevaRelaxdocSocialMDSosido (HC associations)Clinical VillageMedicSpeak

CanadaAsklepiosDoctorNetworking

EuropeDoctors.net.uk (160,000)Escanum (23,000)DocCheck Faces (5,000)ColiquioOnMedica

InternationalNew Media MedicineDoctorsHangoutDoctor.VG Tiromed

Source: Len Starnes, Head of Digital MarketingBayer Schering Pharma

Page 38: Social media: opportunities for pharma

/overview

So, if pharma must join the conversation,

how do we move forward?

Page 39: Social media: opportunities for pharma

Strategy to sandbox

Start with a strategy

Understand core values of social media“We went into it thinking of it as broadcast media and

within a few months we realized we were wrong.”

—Paula Drum, VP of Marketing, H&R Block

Create a sandbox for engagement

Page 40: Social media: opportunities for pharma

3 ideas

1. CSR campaign on Twitter & Facebook

2. Influence the influencers

3. Knowledge-sharing corporate wiki

Page 41: Social media: opportunities for pharma

1. Corporate social responsibility

A new narrative:Enabling citizen philanthropy

Page 42: Social media: opportunities for pharma

Corporate social responsibilityCrate & Barrel’s CEO sent 18,000 $25 gift certificates to their

customers on behalf of DonorsChoose.org.

Page 43: Social media: opportunities for pharma

Corporate social responsibilityCrate & Barrel not only received positive coverage but showed

a 12% increase in merchandise sales by gift certificate redeemers.

Page 44: Social media: opportunities for pharma

Find the right causeGlobal Hug Tour

Page 45: Social media: opportunities for pharma

2. Influence the new influencers

HealthTwitterers

Page 46: Social media: opportunities for pharma

3. Internal wiki

MedpediaWikiHealthWikiSurgerywikiCancerDiabetes WikiMacSurg WikifluwikiRads WikiDocCheck Flexikon wikiECG Pedia.org

Health wikis:

Page 47: Social media: opportunities for pharma

A model corporate wiki: Intel

Page 48: Social media: opportunities for pharma

A model corporate wiki: Intel

# of corporate secrets/unauthorized posts leaked outside the firewall: Zero— Josh Bancroft, founder of Intelpedia,

interview, May 7, 2009

Page 49: Social media: opportunities for pharma

Other ideas

Wellness campaigns

Storytelling with video

Page 50: Social media: opportunities for pharma

Thank you!

Twitter: @jdlasica